Sugi Predict

Sugi Predict / Compounds / 3-Phenethylphenol

3-Phenethylphenol

3-Phenethylphenol

SCHEMBL717571

Oc1cccc(CCc2ccccc2)c1

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ OPRK1 P41145 10/20 0.74
▸ OPRM1 P35372 9/20 0.67
▸ OPRD1 P41143 8/20 0.67
▸ DRD2 P14416 5/20 0.65
▸ DRD1 P21728 1/20 0.65
▸ TAAR1 Q96RJ0 1/20 0.65
▸ DRD3 P35462 4/20 0.62
▸ CHRM2 P08172 1/20 0.59
▸ CHRM1 P11229 1/20 0.59
▸ CHRM3 P20309 1/20 0.59
▸ ENPP2 Q13822 1/20 0.58
▸ NR1H3 Q13133 1/20 0.57
▸ GABRA1 P14867 1/20 0.56
▸ GABRG2 P18507 1/20 0.56
▸ GABRB3 P28472 1/20 0.56
▸ GABRA3 P34903 1/20 0.56
▸ GABRA2 P47869 1/20 0.56
▸ GABRB2 P47870 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Resorcinol SCHEMBL4639098 0.93 OPRK1 (0.64) OPRK1OPRM1OPRD1DRD2DRD1
SCHEMBL723832 0.93 DRD2 (0.74) OPRK1OPRM1OPRD1DRD2DRD1
SCHEMBL5544469 0.91 OPRK1 (0.69) OPRK1OPRM1OPRD1DRD2DRD1
SCHEMBL5542876 0.91 OPRK1 (0.69) OPRK1OPRM1OPRD1DRD2DRD1
SCHEMBL28352345 0.89 OPRK1 (0.67) OPRK1OPRM1OPRD1DRD2DRD1
SCHEMBL5537554 0.89 OPRK1 (0.67) OPRK1OPRM1OPRD1DRD2DRD1
SCHEMBL5542136 0.89 OPRK1 (0.67) OPRK1OPRM1OPRD1DRD2DRD1
Lunularin SCHEMBL717118 0.88 LTA4H (0.64) OPRK1OPRM1OPRD1DRD2DRD1
SCHEMBL6356100 0.86 DRD2 (0.61) OPRK1OPRM1OPRD1DRD2DRD1
SCHEMBL23754287 0.86 GABRA1 (0.67) OPRK1OPRM1OPRD1DRD2DRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112672993-B Novel AUTOTAC chimeric compounds and compositions comprising same for preventing, ameliorating or treating diseases by targeted protein degradation 奧土择破利悟株式会社 2024-03-08 — — CN disclosed
US-11806427-B2 Topical composition containing antioxidants ALPS SOUTH EUROPE, S.R.O. (CZ) 2023-11-07 — — US disclosed
US-20200188878-A1 MOLECULARLY IMPRINTED POLYMERS MONASH UNIVERSITY (AU) 2020-06-18 — — US disclosed
US-20200188878-A1 MOLECULARLY IMPRINTED POLYMERS MONASH UNIVERSITY (AU) 2020-06-18 — — US disclosed
US-20160288090-A1 MOLECULARLY IMPRINTED POLYMERS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2016-10-06 — — US disclosed
US-20160288090-A1 MOLECULARLY IMPRINTED POLYMERS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2016-10-06 — — US disclosed
US-20160288090-A1 MOLECULARLY IMPRINTED POLYMERS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2016-10-06 — — US disclosed
EP-2391658-B1 MOLECULARLY IMPRINTED POLYMERS COMMW SCIENT IND RES ORG (AU) 2015-09-23 — — EP disclosed
CN-102532162-B 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles OTSUKA PHARMA CO LTD 2015-05-27 — — CN disclosed
CN-102604485-B Pigment dispersing agent composite containing phosphate ester structure and preparation method thereof SUZHOU SUNMUN TECHNOLOGY CO LTD 2014-12-17 — — CN disclosed
US-20120052757-A1 MOLECULARLY IMPRINTED POLYMERS MONASH UNIVERSITY (AU) 2012-03-01 — — US disclosed
US-20120052757-A1 MOLECULARLY IMPRINTED POLYMERS MONASH UNIVERSITY (AU) 2012-03-01 — — US disclosed
EP-2391658-A1 MOLECULARLY IMPRINTED POLYMERS Commonwealth Scientific and Industrial Research Organisation (AU) 2011-12-07 — — EP disclosed
WO-2010085851-A1 MOLECULARLY IMPRINTED POLYMERS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2010-08-05 — — WO disclosed
WO-2010085851-A1 MOLECULARLY IMPRINTED POLYMERS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2010-08-05 — — WO disclosed
US-7262212-B2 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-28 — — US disclosed
US-20060094767-A1 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-05-04 — — US disclosed
CN-1705670-A 2, 3-dihydro-6-nitroimidazo [2, 1-b ] oxazole compounds OTSUKA PHARMA CO LTD (JP) 2005-12-07 — — CN disclosed
EP-1555267-A1 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-07-20 — — EP disclosed
US-4077962-A WATER INSOLUBLE, GREEN-YELLOW, SYNTHETIC FIBERS BAYER AKTIENGESELLSCHAFT (DT) 1978-03-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060094767-A1 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles NR2C2, NR4A3, NR4A2 OPRK1 660/4885OPRM1 518/4885OPRD1 159/4885
US-20160288090-A1 MOLECULARLY IMPRINTED POLYMERS IPMK, MPI, PIM3 OPRK1 2181/4885OPRM1 1735/4885OPRD1 3976/4885
US-20120052757-A1 MOLECULARLY IMPRINTED POLYMERS IPMK, MPI, PIM3 OPRK1 2181/4885OPRM1 1735/4885OPRD1 3976/4885
US-11806427-B2 Topical composition containing antioxidants LPO, CAT, SOD3 OPRK1 1886/4885OPRM1 1647/4885OPRD1 2754/4885
US-20200188878-A1 MOLECULARLY IMPRINTED POLYMERS IPMK, MPI, PIM3 OPRK1 2181/4885OPRM1 1735/4885OPRD1 3976/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.